Healthcare Purchasing News
  • Magazine
  • Continuing Education
  • Webinars
  • Whitepapers
  • Videos
  • Events
  • Hall of Fame
  • Advertise
  • Source Guide
  • Subscribe
  • Sourcing & Logistics
  • Sterile Processing
  • Surgical & Critical Care
  • Patient Satisfaction
  • Infection Prevention
  • EVS & Facility Services
  • Healthcare IT
  • Regulatory
  • Topics
    Sourcing & LogisticsSterile ProcessingSurgical & Critical CarePatient SatisfactionInfection PreventionEVS & Facility ServicesHealthcare ITRegulatory
    Resources
    HPN Source GuideContinuing EducationWebinarsWhitepapersVideosEventsHall of FameAdvertiseAd Specs
    User Tools
    SubscribeContact UsAbout UseNewsletterMagazinesPrivacy PolicyTerms & Conditions
    https://www.facebook.com/hpnonline
    https://www.linkedin.com/company/healthcare-purchasing-news/
    https://twitter.com/HPN_Online
    1. Patient Satisfaction
    2. Population Health/Care Continuum

    Genetic testing of the siblings of newborns with cancer genes could reduce rare pediatric cancer deaths by half

    Oct. 20, 2021
    Image by jun yang from Pixabay
    Baby G466d6840b 1920

    Genetic testing of the siblings of newborns found to have mutations in any one of 11 genes most commonly associated with childhood-onset cancers could reduce deaths from these rare cancers by about 50%, suggests a study funded by the National Institutes of Health.

    Moreover, such routine testing could save nearly $17,000 per year for each year of life gained among the siblings, compared to not testing for the mutations. The study, conducted by Grace O’Brien, M.S., of Boston Children’s Hospital, and colleagues, appears in JAMA Network Open. The study was funded by NIH’s Eunice Kennedy Shriver National Institute of Child Health and Human Development and National Human Genome Research Institute.

    Based on current rates for childhood cancers associated with these 11 mutations, the researchers assumed that of an estimated 3.7 million U.S. newborns, 1,584 would have the mutations, 792 of their siblings would also carry these mutations, and 116 of the siblings would develop cancer before age 20. If siblings carrying these mutations were diagnosed at birth and subsequently underwent regular screening, 15 out of 29 deaths before age 20 (52%) would be prevented, saving an estimated $16,910 per year of survival, compared to not routinely testing siblings.

    According to the authors, these benefits are comparable to those found in studies testing the relatives of adult cancer patients with known cancer-causing mutations.

    NIH release

    Latest in Population Health/Care Continuum

    Photo 246006971 © Andrei ASKIRKA | Dreamstime.com
    Regulatory

    New social determinants of health resources released

    Nov. 20, 2023
    Photo 89046596 © Natal'ya Buzuevskaya | Dreamstime.com
    Population Health/Care Continuum

    More than one in three people in the U.S. are at increased risk for type 2 diabetes

    Nov. 20, 2023
    Photo 180279532 © Marek Uliasz | Dreamstime.com
    Population Health/Care Continuum

    FDA announces initiative to ensure pulse oximetry is equitable

    Nov. 20, 2023
    Photo 104326216 | Healthcare © Szefei | Dreamstime.com
    Population Health/Care Continuum

    NIH-funded study says umbilical cord milking appears to be safe in preterm infants born after 28 weeks

    Nov. 9, 2023
    Illustration 83094338 © Lkeskinen0 | Dreamstime.com
    Population Health/Care Continuum

    FDA approves Zepbound (tirzepatide) injection for chronic weight management in adults with obesity

    Nov. 8, 2023
    Healthcare Purchasing News
    https://www.facebook.com/hpnonline
    https://www.linkedin.com/company/healthcare-purchasing-news/
    https://twitter.com/HPN_Online
    • About Us
    • Contact Us
    • Advertise
    • Do Not Sell or Share
    • Privacy Policy
    • Terms & Conditions
    © 2023 Endeavor Business Media, LLC. All rights reserved.
    Endeavor Business Media Logo